Advances in Respiratory and Nasal Drug Delivery

Mol Pharm. 2015 Aug 3;12(8):2561. doi: 10.1021/acs.molpharmaceut.5b00495.

Authors

David Lechuga-Ballesteros^{1

2}, Danforth P Miller^{1

2}

Affiliations

¹ Pearl Therapeutics, Redwood City, California 94063, United States.
² Novartis Pharmaceuticals, San Carlos, California 94070, United States.

PMID: 26235035
DOI: 10.1021/acs.molpharmaceut.5b00495

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Administration, Inhalation
Administration, Intranasal / trends*
Chemistry, Pharmaceutical
Drug Delivery Systems / methods*
Humans
Particle Size
Respiratory Therapy / methods
Respiratory Tract Diseases / drug therapy*